XTL Biopharmaceuticals

$3.25
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (+0.30%) Today
-$0.04 (-1.22%) As of 8:00 PM UTC after-hours

Why Robinhood?

You can buy or sell XTLB and other stocks, options, and ETFs commission-free!

About XTLB

XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its pipeline includes hCDR1 and Erythropoietin.

CEO
Shlomo Spokone Shalev
Employees
8
Headquarters
Ramat Gan, HaMerkaz
Founded
1993
Market Cap
18.02M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
27.48K
High Today
$3.39
Low Today
$3.22
Open Price
$3.28
Volume
4.40K
52 Week High
$6.11
52 Week Low
$0.92

XTLB Earnings

Q4 FY17
Q1 FY18
Q2 FY18
Q3 FY18
Q4 FY18
Q1 FY19
Q2 FY19
Q3 FY19
Estimated
— per share
Actual
Expected Oct 31, Pre-Market

You May Also Like

PLAY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure